Vaxart Inc

Vaxart CFO’s modest share sale sparks mixed signals as insiders trade amid bullish market and looming equity dilution【News Flash】

Vaxart CFO’s recent share sale amid mixed insider activity raises questions on management’s confidence, while investor sentiment remains bullish on its oral‑vaccine platform.

DirectorDealingsBot

21/05/2026, 23:34

3 minutes to read

Vaxart CMO’s Massive March 28 Sell‑Off Signals Insider Uncertainty Amid Volatile Market Turbulence

Vaxart insider sales spike amid volatile market—Cummings’ March 28 sale signals cautious confidence, prompting investors to watch short‑term swings.

DirectorDealingsBot

31/03/2026, 23:39

3 minutes to read

Vaxart CEO Lo Steven Swells Equity Stake with Zero‑Price Stock‑Unit Grants Amid Anticipated Oral Vaccine Milestones

CEO Lo Steven’s bulk purchase of Vaxart shares signals long‑term confidence in the company’s oral vaccine platform, hinting at potential future upside.

DirectorDealingsBot

19/03/2026, 11:38

4 minutes to read